[1]Thuss Patience PC, Kretzschmar A, Reichardt P. Docetaxel in the treatment of gastric cancer. Future Oncol.2006;2(5): 603-620.[2]Janeway KA, Grier HE. Sequelae of osteosarcoma medical therapy: a review of rare acute toxicities and late effects. Lancet Oncol.2010; 11(7):670-678.[3]Wang SB,Guo KY,Hu DM,et al.Zhongguo Zuzhi Gongcheng Yanjiu yu Linchuang Kangfu.2008;12(25):4811-4813.王三斌,郭坤元,胡灯明,等.以SEAM预处理方案行自体外周血干细胞移植治疗非何杰金淋巴瘤[J].中国组织工程研究与临床康复, 2008,12(25):4811-4813.[4]Vranovsky A,Ladicka M,Lakota J.Autologous stem cell transplantion in first-line treatment of high-risk aggressive non-Hodgkin's lymphoma.Neoplasma.2008;55(2):107-112.[5]Hamlin PA,Zelenetz AD,Kewalramani T, et al. Age adjusted International Prognostic Index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma. Blood.2003; 02(6): 1989-1996.[6]Espigado I,Ros E,Marn-Niebla A,et al.High rate of longterm survival for high-risk lymphoma patients treated with hematopoietic stem cell transplantation as consolidation or salvage therapy. Transplant Proc. 2008;40(9):3104-3105.[7]Li SQ,Chen DD,Gao LZ.Zhongguo Linchuang Yaolixue yu Zhiliaoxue.2008;13(2):201-207.李胜前,陈丁丁,高利忠.河鲀Ⅰ型胶原蛋白提取物防治环磷酰胺、顺铂或阿糖胞苷诱发小鼠骨髓抑制的研究[J].中国临床药理学与治疗学.2008;13(2):201-207.[8]In 't Anker PS, Scherjon SA, Kleijburg-van der Keur C, et al.Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells.2004;22(7): 1338-1345.[9]Parolini O,Alviano F,Bagnara GP,etal.Concise review:isolation and characterization of cells from human term placenta:outcome of the first international Workshop on Placenta Derived Stem Cells.Stem Cells. Stem Cells.2008; 26(2):300-311.[10]Li GX,Yang B,Guan FX,etal.Zhengzhou Daxue Xuebao: Yixueban. 2006;41(2): 244 -247.李国喜,杨波,关方霞,等.人羊膜来源间质干细胞的分离、培养及鉴定[J].郑州大学学报(医学版).2006;41(2):244-247. [11]Sakuragawa N,Enosawa S,Ishii T,et al.Human amniotic epithelial cells are promising transgene carriers for allogeneic cell transplantation into liver.J Hum Genet.2000;45:171-176.[12]Reyes M, Dudek A, Jahagirdar B, et al. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 2002;109 (3):337-346.[13]The Ministry of Science and Technology of the People’s Republic of China. Guidance Suggestions for the Care and Use of Laboratory Animals. 2006-09-30.中华人民共和国科学技术部. 关于善待实验动物的指导性意见. 2006-09-30.[14]Fang N,Zhang L,Song XJ,et al.Zunyi Yixueyuan Xuebao. 2009; 32(3):234-236.方宁,张路,宋秀军,等.人羊膜间充质干细胞的分离、培养及鉴定[J].遵义医学院学报,2009,32(3):234-236.[15]Chen Q.Beijing:People’s Medical Publishing House. 2006: 1167.陈奇.中药药理研究方法学[M].北京:人民卫生出版社,2006: 1167.[16]Carey PJ.Drug-induced myelosuppression:diagnosis and management. Drug Saf.2003;26:691-706.[17]Chen Y,Shao JZ,Xiang LX et al.Mesenchymal stem cells: a promising candidate in regenerative medicine. Int J Biochem Cell Biol.2008;40:815.[18]Niwa H,Masui S,Chambers I,et al. Phenotypic complementation establishes requirements for specific POU domain and generic transactivation function of Oct-3/4 in embryonic stem cells.Mol Cell Biol.2002;22(5):1526-1536.[19]Strem BM,Hicok KC,Zhu M,et al.Multipotential different tiation of adipose tissue-derived stem cells.Keio J Med.2005; 54: 132-141[20]Moon J H,Lee JR,Jee BC,et al.Successful vitrification of human amnion- derived mesenchymal stem cells.Hum Reprod.2008;23(8):1760 -1770.[21]Wolbank S,Peterbauer A,Fahrner M,et al.Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane:A comparison with human mesenchymal stem cells from adiposetissue.Tissue Eng.2007;13(6):1173- 1183.[22]Kobayashi M,Yakuwa T,Sasaki K,et a1.Multilineage potential of side population cells from human amnion mesenchymal layer. Cell Transplantation, 2008;(17):291-301[23]Kita K,Gauglitz GG,Phan TT,et al.Isolation and characterization of mesenchymal stem cells from the sub-amniotic human umbilical cord lining membrane.Stem Cells Dev.2010;19(4):491-502. |